Oct 24, 2017 • 9:06 am EDT Corbus Pharmaceuticals Holdings, Inc. Prices Underwritten Public Offering of Common Stock
Oct 23, 2017 • 4:01 pm EDT Corbus Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering of Common Stock
Oct 19, 2017 • 7:30 am EDT Corbus Pharmaceuticals Reports Positive Topline Results from Phase 2 Study in Rare Autoimmune Disease Dermatomyositis
Oct 17, 2017 • 7:30 am EDT Corbus Pharmaceuticals Appoints Paris Panayiotopoulos to Its Board of Directors
Sep 25, 2017 • 7:00 am EDT Corbus Pharmaceuticals Announces Presentation of Three Abstracts at the 2017 North American Cystic Fibrosis Conference
Sep 20, 2017 • 8:00 am EDT Corbus Pharmaceuticals Announces Presentation of Six Abstracts and New Anabasum Data at 2017 ACR Annual Meeting
Sep 14, 2017 • 8:00 am EDT Corbus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
Aug 31, 2017 • 8:05 am EDT Corbus Pharmaceuticals to Host Fireside Chat on Dermatomyositis with Expert Physician and Researcher, Victoria Werth, MD
Aug 9, 2017 • 7:05 am EDT Corbus Pharmaceuticals Reports 2017 Second Quarter Financial Results and Provides Business Update
Aug 7, 2017 • 7:05 am EDT Corbus Pharmaceuticals to Present New Data from Systemic Sclerosis Phase 2 Study of Anabasum at the 15th International Workshop on Scleroderma Research